Copyright
©The Author(s) 2023.
World J Gastrointest Oncol. Nov 15, 2023; 15(11): 1913-1924
Published online Nov 15, 2023. doi: 10.4251/wjgo.v15.i11.1913
Published online Nov 15, 2023. doi: 10.4251/wjgo.v15.i11.1913
Figure 1 Tumor location and progression-free survival and overall survival.
A: Progression-free survival; B: Overall survival. OS: Overall survival; PFS: Progression-free survival; HR: Hazard ratio; 95%CI: 95% confidence interval.
- Citation: Mullin G, Sternschuss M, Landman Y, Sulkes A, Brenner B. Mitomycin C and capecitabine: An additional option as an advanced line therapy in patients with metastatic colorectal cancer. World J Gastrointest Oncol 2023; 15(11): 1913-1924
- URL: https://www.wjgnet.com/1948-5204/full/v15/i11/1913.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v15.i11.1913